Exchange: NYSE·Updated 07:30 PM EST

WST Earnings

Latest Earnings Results: Q3 '26

Reported: Oct 29

Estimated EPS

$2.20

Reported EPS

$2.66

Surprise

+20.86%

Estimated Rev

$827.12M

Reported Rev

$874.5M

Surprise

+5.73%

• Reported GAAP EPS of $2.66 up 35.71% YoY • Reported revenue of $874.5M up 8.69% YoY • West Pharmaceutical Services increased full-year 2026 net sales guidance to $3.41B to $3.42B and adjusted-diluted EPS guidance to $9.38 to $9.48, both increased from prior guidance.

Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Investor Presentation10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q4 '26
$2.29
--
--
N/A
Q3 '26
$2.20
$2.66
20.86%
BEAT
Q2 '26
$2.08
$2.37
13.86%
BEAT
Q1 '26
$1.68
$2.13
26.94%
BEAT
Q4 '25
$1.83
$2.04
11.62%
BEAT

Advertisement|Remove ads.